AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that influenza drug market sales will reach $2.5 billion in 2012.
According to a new Pharmacor study entitled "Influenza," MedImmune's FluMist and one other intranasal vaccine will account for 60% of the market in 2012.
"MedImmune's FluMist, the first intranasal vaccine and first live-attenuated vaccine for influenza, has been approved by the FDA [Food and Drug Adminstration] and has entered the market in time for the 2003/2004 influenza season," said Jason LaBonte, PhD, analyst at Decision Resources. "FluMist's launch signals an abrupt upward ...
Source: HighBeam Research, Report: Influenza drug market sales to reach $2.5 billion in 2012.